Ogitani; Yusuke
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ogitani; Yusuke.The latest application filed is for "combination of antibody-drug conjugate with parp inhibitor".
- Ogitani; Yusuke - Tokyo JP
| Patent | Date |
|---|---|
| Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate Grant 11,261,261 - Naito , et al. March 1, 2 | 2022-03-01 |
| Combination Of Antibody-drug Conjugate With Parp Inhibitor App 20220023436 - OGITANI; Yusuke ; et al. | 2022-01-27 |
| (Anti-HER2 antibody)-drug conjugate Grant 11,185,594 - Naito , et al. November 30, 2 | 2021-11-30 |
| Combination Of Antibody-drug Conjugate And Tubulin Inhibitor App 20210290775 - OGITANI; Yusuke ; et al. | 2021-09-23 |
| Antibody-drug conjugate Grant 10,973,924 - Masuda , et al. April 13, 2 | 2021-04-13 |
| Method Of Treating Cancer Comprising Administration Of Anti-her2 Antibody-drug Conjugate App 20200385486 - NAITO; Hiroyuki ; et al. | 2020-12-10 |
| Antibody-drug Conjugate App 20200282073 - MASUDA; Takeshi ; et al. | 2020-09-10 |
| Antibody-drug conjugate produced by binding through linker having hydrophilic structure Grant 10,729,782 - Naito , et al. | 2020-08-04 |
| Therapy For Drug-resistant Cancer By Administration Of Anti-her2 Antibody/drug Conjugate App 20190330368 - JIKOH; Takahiro ; et al. | 2019-10-31 |
| Anti-her2 Antibody-drug Conjugate App 20190077880 - NAITO; Hiroyuki ; et al. | 2019-03-14 |
| Antibody-drug conjugate Grant 10,195,288 - Masuda , et al. Fe | 2019-02-05 |
| Antibody-drug Conjugate App 20190008981 - Masuda; Takeshi ; et al. | 2019-01-10 |
| Anti-HER2 antibody-drug conjugate Grant 10,155,821 - Naito , et al. Dec | 2018-12-18 |
| Antibody-drug Conjugate Produced By Binding Through Linker Having Hydrophilic Structure App 20180071403 - NAITO; Hiroyuki ; et al. | 2018-03-15 |
| Antibody-drug conjugate produced by binding through linker having hydrophilic structure Grant 9,872,924 - Naito , et al. January 23, 2 | 2018-01-23 |
| Antibody-drug conjugate Grant 9,808,537 - Masuda , et al. November 7, 2 | 2017-11-07 |
| (anti-her2 Antibody)-drug Conjugate App 20170035906 - NAITO; Hiroyuki ; et al. | 2017-02-09 |
| Anti-her2 Antibody-drug Conjugate App 20160333112 - NAITO; Hiroyuki ; et al. | 2016-11-17 |
| Antibody-drug Conjugate App 20160279259 - Masuda; Takeshi ; et al. | 2016-09-29 |
| Antibody-drug Conjugate Produced By Binding Through Linker Having Hydrophilic Structure App 20150352224 - NAITO; Hiroyuki ; et al. | 2015-12-10 |
| Antibody-drug Conjugate App 20150297748 - MASUDA; Takeshi ; et al. | 2015-10-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 